IL93663A - Preparations containing annular diuretics to treat allergic reactions caused by allergens - Google Patents

Preparations containing annular diuretics to treat allergic reactions caused by allergens

Info

Publication number
IL93663A
IL93663A IL9366390A IL9366390A IL93663A IL 93663 A IL93663 A IL 93663A IL 9366390 A IL9366390 A IL 9366390A IL 9366390 A IL9366390 A IL 9366390A IL 93663 A IL93663 A IL 93663A
Authority
IL
Israel
Prior art keywords
allergen
nasal
furosemide
placebo
reactions
Prior art date
Application number
IL9366390A
Other languages
English (en)
Hebrew (he)
Other versions
IL93663A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL93663A0 publication Critical patent/IL93663A0/xx
Publication of IL93663A publication Critical patent/IL93663A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)
IL9366390A 1989-03-08 1990-03-06 Preparations containing annular diuretics to treat allergic reactions caused by allergens IL93663A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3907414A DE3907414A1 (de) 1989-03-08 1989-03-08 Die anwendung inhalierter schleifendiuretika zur behandlung von allergen-induzierten nasalen reaktionen

Publications (2)

Publication Number Publication Date
IL93663A0 IL93663A0 (en) 1990-12-23
IL93663A true IL93663A (en) 1994-11-11

Family

ID=6375791

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9366390A IL93663A (en) 1989-03-08 1990-03-06 Preparations containing annular diuretics to treat allergic reactions caused by allergens

Country Status (18)

Country Link
US (1) US5392767A (el)
EP (1) EP0386700B1 (el)
JP (1) JPH02279625A (el)
KR (1) KR900013955A (el)
CN (1) CN1045350A (el)
AT (1) ATE82853T1 (el)
AU (1) AU623502B2 (el)
CA (1) CA2011680A1 (el)
DD (1) DD292380A5 (el)
DE (2) DE3907414A1 (el)
DK (1) DK0386700T3 (el)
ES (1) ES2052998T3 (el)
GR (1) GR3007175T3 (el)
HU (1) HU205852B (el)
IE (1) IE900811L (el)
IL (1) IL93663A (el)
NO (1) NO901078L (el)
ZA (1) ZA901747B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0465841A3 (en) * 1990-06-13 1992-10-14 Hoechst Aktiengesellschaft Quick acting pharmaceutical inhalation forms of diuretics
DE4023086A1 (de) * 1990-07-20 1992-01-23 Hoechst Ag Methode zur behandlung von allergischer konjunktivitis
EP0499142A3 (en) * 1991-02-09 1993-05-05 Hoechst Aktiengesellschaft Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
WO1999016417A1 (en) 1997-10-01 1999-04-08 Flemington Pharmaceutical Corporation Buccal, polar and non-polar spray or capsule
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US7231919B2 (en) 2001-09-28 2007-06-19 Kurve Technology, Inc. Particle dispersion device for nasal delivery
US8168674B1 (en) * 2002-02-22 2012-05-01 Microdose Therapeutx, Inc. Method for treating bronchial diseases
AU2003249623A1 (en) * 2002-05-09 2003-12-12 Kurve Technology, Inc. Particle dispersion chamber for nasal nebulizer
EP1673123A2 (en) * 2003-09-05 2006-06-28 Kurve Technology, Inc. Integrated nebulizer and particle dispersing chamber for delivery of medicament
WO2005023334A2 (en) * 2003-09-05 2005-03-17 Kurve Technology, Inc. Nasal adapter for the base of the nose
WO2008028092A2 (en) 2006-08-30 2008-03-06 Kurve Technology, Inc. Aerosol generating and delivery device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3500M (fr) * 1964-06-15 1965-08-23 Fo We Forschungs Und Verwertun Nouveau médicament destiné au traitement des rhinites.
NZ209900A (en) * 1984-10-16 1989-08-29 Univ Auckland Automatic inhaler
US4886811A (en) * 1988-10-24 1989-12-12 Merrell Dow Pharmaceuticals Qunolyloxazole-2-ones useful as proteinkinase C inhibitors
JPH0720862B2 (ja) * 1989-01-27 1995-03-08 ヘキスト・アクチエンゲゼルシヤフト 吸入用喘息治療剤

Also Published As

Publication number Publication date
CN1045350A (zh) 1990-09-19
CA2011680A1 (en) 1990-09-08
EP0386700A1 (de) 1990-09-12
HU901321D0 (en) 1990-05-28
JPH02279625A (ja) 1990-11-15
AU5075090A (en) 1990-10-11
NO901078D0 (no) 1990-03-07
DE3907414A1 (de) 1990-09-13
US5392767A (en) 1995-02-28
HUT52953A (en) 1990-09-28
AU623502B2 (en) 1992-05-14
DE59000518D1 (de) 1993-01-14
ES2052998T3 (es) 1994-07-16
NO901078L (no) 1990-09-10
IE900811L (en) 1990-09-08
KR900013955A (ko) 1990-10-22
IL93663A0 (en) 1990-12-23
ATE82853T1 (de) 1992-12-15
DD292380A5 (de) 1991-08-01
EP0386700B1 (de) 1992-12-02
ZA901747B (en) 1990-11-28
GR3007175T3 (el) 1993-07-30
HU205852B (en) 1992-07-28
DK0386700T3 (da) 1993-03-01

Similar Documents

Publication Publication Date Title
IL93663A (en) Preparations containing annular diuretics to treat allergic reactions caused by allergens
DE60210402T2 (de) System zur Abgabe einer Tobramycin-Formulierung
Robinson et al. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study
KR100234864B1 (ko) 기도 및 폐질환을 치료하기 위한 모메타손푸로에이트 약제
KR100910888B1 (ko) 에어로졸화 이송을 위한 적절한 토브라마이싱의 조성물
DE69724991T2 (de) Behandlung von bronchitis mit diuridintretraphosphat
JPH0669957B2 (ja) グルタチオンのエーロゾル製剤
EP1673074B1 (de) Flüssige zubereitung enthaltend tobramycin
US6623723B2 (en) Method for treating bronchial constriction and bronchospasm
Rodgers et al. The effect of topical benzamil and amiloride on nasal potential difference in cystic fibrosis
JPH0720862B2 (ja) 吸入用喘息治療剤
Chatterjee et al. Intra‐nasal beclomethasone dipropionate and intra‐nasal sodium cromoglycate: a comparative trial
CN109195580A (zh) 具有弹性蛋白酶抑制活性的β-发夹肽模拟物及其气雾剂剂量形式
EP0240907A2 (de) Verwendung von trans-4-[(2-Amino-3,5-dibrom-benzyl)-amino]cyclohexanol
EP0756486A1 (en) Pharmaceutical inhalation compositions containing a solid active ingredient
Jenkins et al. Comparison of ipratropium bromide and salbutamol by aerosolized solution
Prime The assessment of antitussive drugs in man
US20110200647A1 (en) Pulmonary disease treatment
Pedersen et al. Powder administration of pure budesonide for the treatment of seasonal allergic rhinitis
Ahmed et al. Comparative effects of oral and inhaled verapamil on antigen-induced bronchoconstriction
EP2826479B1 (en) Ameliorating agent for chronic obstructive pulmonary disease
JP2002205942A (ja) 局所適用組成物
Chatterjee et al. Beclomethasone dipropionate in asthma: a comparison of two methods of administration
WO2010009288A1 (en) Compositions and uses of antiviral active pharmaceutical agents
Smith et al. Comparison of nebuliser efficiency for aerosolizing pentamidine

Legal Events

Date Code Title Description
RH Patent void